Nautilus Biotech Closes EUR8.4 Million ($11.3 Million) Investment Funding

Published: Apr 30, 2007

PARIS, April 30 /PRNewswire/ -- Nautilus Biotech, a leading biotechnology company, has announced that it has raised EUR8.4 million ($11.3 million) in investment funding. The investors in this round include Creabilis Biotech, Ed. de Rothschild Investment Partners, Auriga Partners, Matignon Technologies, Pre-IPO Invest, FCJE, 123 Ventures and Genopole®. The legal advisors were Hammonds Hausmann.

Back to news